The Transcellular Propagation and Intracellular Trafficking of α-Synuclein

Overview

Journal Cold Spring Harb Perspect Med

Specialty General Medicine

Date 2016 Dec 7

PMID 27920026

Citations 18

Authors

George K Tofaris

Michel Goedert

Maria Grazia Spillantini

Affiliations

Soon will be listed here.

Abstract

Parkinson's disease is the second most common neurodegenerative disorder, with only partial symptomatic therapy and no mechanism-based therapies. The accumulation and aggregation of α-synuclein is causatively linked to the sporadic form of the disease, which accounts for 95% of cases. The pathology is a result of a gain of toxic function of misfolded α-synuclein conformers, which can template the aggregation of soluble monomers and lead to cellular dysfunction, at least partly by interfering with membrane fusion events at synaptic terminals. Here, we discuss the transcellular propagation and intracellular trafficking of α-synuclein and posit that endosomal processing could be a point of convergence between these two routes. Understanding these events will clarify the therapeutic potential of enzymes that regulate protein trafficking and degradation in synucleinopathies.

Citing Articles

Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model.

Geerts H, Bergeler S, Walker M, van der Graaf P, Courade J Sci Rep. 2023; 13(1):14342.

PMID: 37658103 PMC: 10474108. DOI: 10.1038/s41598-023-41382-0.

Monitoring α-synuclein Aggregation Induced by Preformed α-synuclein Fibrils in an Model System.

Kim B, Noh H, Jeon H, Park S Exp Neurobiol. 2023; 32(3):147-156.

PMID: 37403223 PMC: 10327928. DOI: 10.5607/en23007.

Cellular processing of α-synuclein fibrils results in distinct physiological C-terminal truncations with a major cleavage site at residue Glu 114.

Quintin S, Lloyd G, Paterno G, Xia Y, Sorrentino Z, Bell B J Biol Chem. 2023; 299(7):104912.

PMID: 37307916 PMC: 10404685. DOI: 10.1016/j.jbc.2023.104912.

The role of the endolysosomal pathway in α-synuclein pathogenesis in Parkinson's disease.

Smith J, Mellick G, Sykes A Front Cell Neurosci. 2023; 16:1081426.

PMID: 36704248 PMC: 9871505. DOI: 10.3389/fncel.2022.1081426.

Neuronal haemoglobin induces loss of dopaminergic neurons in mouse Substantia nigra, cognitive deficits and cleavage of endogenous α-synuclein.

Santulli C, Bon C, De Cecco E, Codrich M, Narkiewicz J, Parisse P Cell Death Dis. 2022; 13(12):1048.

PMID: 36526614 PMC: 9758156. DOI: 10.1038/s41419-022-05489-y.

References

Feany M, Bender W . A Drosophila model of Parkinson's disease. Nature. 2000; 404(6776):394-8. DOI: 10.1038/35006074. View

Giasson B, Murray I, Trojanowski J, Lee V . A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem. 2000; 276(4):2380-6. DOI: 10.1074/jbc.M008919200. View

Abdul-Ghani M, Gougeon P, Prosser D, Ngsee J . PRA isoforms are targeted to distinct membrane compartments. J Biol Chem. 2000; 276(9):6225-33. DOI: 10.1074/jbc.M009073200. View

Uversky V, Li J, Fink A . Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J Biol Chem. 2001; 276(14):10737-44. DOI: 10.1074/jbc.M010907200. View

Sung J, Kim J, Paik S, Park J, Ahn Y, Chung K . Induction of neuronal cell death by Rab5A-dependent endocytosis of alpha-synuclein. J Biol Chem. 2001; 276(29):27441-8. DOI: 10.1074/jbc.M101318200. View

Li J, Uversky V, Fink A . Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. Biochemistry. 2001; 40(38):11604-13. DOI: 10.1021/bi010616g. View

Lashuel H, Hartley D, Petre B, Walz T, Lansbury Jr P . Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature. 2002; 418(6895):291. DOI: 10.1038/418291a. View

Braak H, Del Tredici K, Rub U, de Vos R, Jansen Steur E, Braak E . Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2002; 24(2):197-211. DOI: 10.1016/s0197-4580(02)00065-9. View

Webb J, Ravikumar B, Atkins J, Skepper J, Rubinsztein D . Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem. 2003; 278(27):25009-13. DOI: 10.1074/jbc.M300227200. View

10.

Tofaris G, Razzaq A, Ghetti B, Lilley K, Spillantini M . Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J Biol Chem. 2003; 278(45):44405-11. DOI: 10.1074/jbc.M308041200. View

11.

Hoshikawa C, Shichiri M, Nakamori S, Takagi H . A nonconserved Ala401 in the yeast Rsp5 ubiquitin ligase is involved in degradation of Gap1 permease and stress-induced abnormal proteins. Proc Natl Acad Sci U S A. 2003; 100(20):11505-10. PMC: 208788. DOI: 10.1073/pnas.1933153100. View

12.

El-Agnaf O, Salem S, Paleologou K, Cooper L, Fullwood N, Gibson M . Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J. 2003; 17(13):1945-7. DOI: 10.1096/fj.03-0098fje. View

13.

Outeiro T, Lindquist S . Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science. 2003; 302(5651):1772-5. PMC: 1780172. DOI: 10.1126/science.1090439. View

14.

Cuervo A, Stefanis L, Fredenburg R, Lansbury P, Sulzer D . Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004; 305(5688):1292-5. DOI: 10.1126/science.1101738. View

15.

Choi W, Zibaee S, Jakes R, Serpell L, Davletov B, Crowther R . Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein. FEBS Lett. 2004; 576(3):363-8. DOI: 10.1016/j.febslet.2004.09.038. View

16.

Greenbaum E, Graves C, Mishizen-Eberz A, Lupoli M, Lynch D, Englander S . The E46K mutation in alpha-synuclein increases amyloid fibril formation. J Biol Chem. 2005; 280(9):7800-7. DOI: 10.1074/jbc.M411638200. View

17.

Lee H, Patel S, Lee S . Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci. 2005; 25(25):6016-24. PMC: 6724798. DOI: 10.1523/JNEUROSCI.0692-05.2005. View

18.

Chandra S, Gallardo G, Fernandez-Chacon R, Schluter O, Sudhof T . Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell. 2005; 123(3):383-96. DOI: 10.1016/j.cell.2005.09.028. View

19.

Sang Q, Kim M, Kumar S, Bye N, Morganti-Kossman M, Gunnersen J . Nedd4-WW domain-binding protein 5 (Ndfip1) is associated with neuronal survival after acute cortical brain injury. J Neurosci. 2006; 26(27):7234-44. PMC: 6673957. DOI: 10.1523/JNEUROSCI.1398-06.2006. View

20.

Anderson J, Walker D, Goldstein J, de Laat R, Banducci K, Caccavello R . Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem. 2006; 281(40):29739-52. DOI: 10.1074/jbc.M600933200. View